Bristol-Myers Squibb: Building Billion-Dollar Device Businesses

Focusing on franchises not individual products, BMS is developing strategies for its Zimmer and ConvaTec divisions that enable them to grow at once independently and synergistically. BMS is exploring potential links between its various businesses which capitalize on new market or technology opportunities without sacrificing the skills that made each company successful.

by David Cassak

Most medical device companies have historically inhabited comfortably insular niches. De-fining their strengths in terms of narrowly defined customer groups...

More from Archive

More from In Vivo